HCA HCA Healthcare
NYSE · SEC CIK 860730 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $31.12M 6 sales by 5 insiders
- Filings on record
- 323 since 2021-07-23, latest 2026-08-28 13:00
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| HAZEN SAMUEL N | CEO, Dir | — | $21.48M |
| Berres Jennifer | SVP, Chief Human Res. Off | — | $4.13M |
| McAlevey Michael R | EVP, Chief Legal, Admin Off | — | $2.75M |
| Wyatt Christopher F. | SVP, Ctrl | — | $2.02M |
| Cuffe Michael S. | EVP, Chief Clinical Off | — | $747.1K |
| Rossitto Erica | SVP, Chief Nurse Executive | — | — |
| Marks Mike A | EVP, CFO | — | — |
| Smith Andrea B | Dir | — | — |
| Foster Jon M | EVP, COO | — | — |
| Frist William R | Dir, 10% | — | — |
Transactions 488
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-05 | 2025-02-03 | HCA | Mosier Sammie S | SVP, Chief Nurse Executive | F - Tax | $334.30 | -41 | 10.5K | -0.4% | -$13.7K |
| D | 2025-02-05 | 2025-02-03 | HCA | Mosier Sammie S | SVP, Chief Nurse Executive | M - OptEx | — | +138 | 10.5K | +1% | — |
| 2024-11-18 | 2024-11-14 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | S - Sale | $357.99 | -1,474 | 9,454 | -13% | -$527.7K | |
| DMI | 2024-11-18 | 2024-05-15+ | HCA | Foster Jon M | EVP, COO | G - Gift | $0.00 | +20.0K | 18.0K | New | $0 |
| D | 2024-11-18 | 2024-11-14 | HCA | Foster Jon M | EVP, COO | J - Other | $352.74 | -9,502 | 30.5K | -24% | -$3.35M |
| DI | 2024-11-18 | 2024-11-14 | HCA | Foster Jon M | EVP, COO | J - Other | $352.74 | +9,502 | 64.6K | +17% | +$3.35M |
| D | 2024-11-18 | 2024-11-14 | HCA | Foster Jon M | EVP, COO | F - Tax | $345.51 | -20.9K | 26.3K | -44% | -$7.22M |
| DM | 2024-11-18 | 2024-11-14 | HCA | Foster Jon M | EVP, COO | G - Gift | $0.00 | -20.0K | 28.6K | -41% | $0 |
| D | 2024-11-18 | 2024-11-14 | HCA | Foster Jon M | EVP, COO | M - OptEx | $101.16 | +36.6K | 47.2K | +346% | +$3.70M |
| D | 2024-11-14 | 2024-11-12 | HCA | Billington Phillip G | SVP-Internal Audit Services | M - OptEx | $68.96 | +8,000 | 60.7K | +15% | +$551.7K |
| D | 2024-11-14 | 2024-11-14 | HCA | Billington Phillip G | SVP-Internal Audit Services | S - Sale+OE | $350.00 | -3,897 | 52.7K | -7% | -$1.36M |
| D | 2024-11-14 | 2024-11-12 | HCA | Billington Phillip G | SVP-Internal Audit Services | F - Tax | $350.53 | -4,103 | 56.6K | -7% | -$1.44M |
| D | 2024-11-14 | 2024-11-12 | HCA | Akdamar Erol R | Group Pres | F - Tax | $350.53 | -10.3K | 9,743 | -51% | -$3.60M |
| D | 2024-11-14 | 2024-11-12 | HCA | Akdamar Erol R | Group Pres | M - OptEx | $68.96 | +20.0K | 20.0K | New | +$1.38M |
| D | 2024-11-14 | 2024-11-14 | HCA | Akdamar Erol R | Group Pres | S - Sale+OE | $353.00 | -2,900 | 6,843 | -30% | -$1.02M |
| D | 2024-11-13 | 2024-11-11 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | F - Tax | $357.99 | -3,236 | 10.9K | -23% | -$1.16M |
| D | 2024-11-13 | 2024-11-11 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | M - OptEx | $173.12 | +4,710 | 14.2K | +50% | +$815.4K |
| MI | 2024-11-01 | 2024-10-30 | HCA | Elcan Patricia F | 10% | J - Other | $361.55 | 0 | 0 | New | $0 |
| DT | 2024-09-12 | 2024-09-10 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | F - Tax | $386.43 | -13.7K | 38.0K | -27% | -$5.30M |
| DT | 2024-09-12 | 2024-09-10 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | M - OptEx | $145.24 | +22.1K | 51.8K | +74% | +$3.21M |
| DT | 2024-09-12 | 2024-09-12 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | S - Sale+OE | $385.42 | -8,358 | 29.7K | -22% | -$3.22M |
| I | 2024-08-12 | 2024-08-08 | HCA | Marks Mike A | EVP, CFO | G - Gift | $0.00 | +2,237 | 43.2K | +5% | $0 |
| 2024-08-12 | 2024-08-08 | HCA | Marks Mike A | EVP, CFO | G - Gift | $0.00 | -2,237 | 0 | -100% | $0 | |
| M | 2024-08-08 | 2024-08-06 | HCA | HAZEN SAMUEL N | CEO, Dir | G - Gift | $0.00 | -22.2K | 63.2K | -26% | $0 |
| MI | 2024-08-08 | 2024-08-06+ | HCA | HAZEN SAMUEL N | CEO, Dir | G - Gift | $0.00 | +22.2K | 15.0K | New | $0 |
| 2024-08-07 | 2024-08-05 | HCA | Sowell Joseph A III | SVP, Chief Development Off | G - Gift | $0.00 | -13.4K | 0 | -100% | $0 | |
| I | 2024-08-07 | 2024-08-05 | HCA | Sowell Joseph A III | SVP, Chief Development Off | G - Gift | $0.00 | +13.4K | 18.5K | +259% | $0 |
| D | 2024-08-02 | 2024-07-31 | HCA | McManus Timothy M | Group Pres | F - Tax | $363.05 | -3,919 | 27.0K | -13% | -$1.42M |
| D | 2024-08-02 | 2024-07-31 | HCA | McManus Timothy M | Group Pres | M - OptEx | $77.13 | +7,500 | 30.9K | +32% | +$578.5K |
| 2024-07-31 | 2024-07-29 | HCA | Reiner Deborah M | SVP - Mktg, Comms | S - Sale | $359.96 | -3,314 | 3,510 | -49% | -$1.19M | |
| DM | 2024-07-31 | 2024-07-29+ | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | S - Sale+OE | $362.13 | -4,851 | 9,454 | -34% | -$1.76M |
| D | 2024-07-31 | 2024-07-29 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | F - Tax | $358.73 | -5,293 | 14.3K | -27% | -$1.90M |
| D | 2024-07-31 | 2024-07-29 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | M - OptEx | $145.24 | +8,280 | 19.6K | +73% | +$1.20M |
| D | 2024-07-29 | 2024-07-25 | HCA | Wyatt Christopher F. | SVP, Ctrl | M - OptEx | $101.16 | +9,300 | 49.7K | +23% | +$940.8K |
| D | 2024-07-29 | 2024-07-25 | HCA | Wyatt Christopher F. | SVP, Ctrl | F - Tax | $352.79 | -5,278 | 44.4K | -11% | -$1.86M |
| D | 2024-07-29 | 2024-07-29 | HCA | Wyatt Christopher F. | SVP, Ctrl | S - Sale+OE | $360.20 | -4,000 | 40.4K | -9% | -$1.44M |
| 2024-07-29 | 2024-07-25 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | S - Sale | $355.05 | -1,857 | 17.8K | -9% | -$659.3K | |
| D | 2024-05-20 | 2024-05-16 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | S - Sale+OE | $326.30 | -3,204 | 9,454 | -25% | -$1.05M |
| D | 2024-05-20 | 2024-05-17 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | F - Tax | $322.86 | -2,861 | 11.3K | -20% | -$923.7K |
| DM | 2024-05-20 | 2024-05-17 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | M - OptEx | $112.70 | +4,725 | 12.5K | +61% | +$532.5K |
| D | 2024-05-17 | 2024-05-15 | HCA | Sowell Joseph A III | SVP, Chief Development Off | M - OptEx | $68.96 | +19.0K | 23.3K | +444% | +$1.31M |
| D | 2024-05-17 | 2024-05-15 | HCA | Sowell Joseph A III | SVP, Chief Development Off | F - Tax | $326.96 | -9,908 | 13.4K | -43% | -$3.24M |
| DM | 2024-05-17 | 2024-05-15 | HCA | Foster Jon M | EVP, COO | M - OptEx | $78.21 | +39.5K | 61.3K | +181% | +$3.09M |
| D | 2024-05-17 | 2024-05-15 | HCA | Foster Jon M | EVP, COO | F - Tax | $326.96 | -21.3K | 40.0K | -35% | -$6.95M |
| 2024-05-17 | 2024-05-15 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | S - Sale | $326.18 | -1,863 | 19.6K | -9% | -$607.7K | |
| 2024-05-13 | 2024-05-09 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | S - Sale | $316.88 | -6,311 | 29.6K | -18% | -$2.00M | |
| 2024-05-13 | 2024-05-09 | HCA | Akdamar Erol R | Group Pres | G - Gift | $0.00 | -5,139 | 0 | -100% | $0 | |
| I | 2024-05-13 | 2024-05-09 | HCA | Akdamar Erol R | Group Pres | G - Gift | $0.00 | +5,139 | 60.5K | +9% | $0 |
| 2024-05-13 | 2024-05-09 | HCA | Cohen Jeffrey E. | SVP-Government Relations | S - Sale | $313.00 | -1,650 | 5,185 | -24% | -$516.5K | |
| D | 2024-05-08 | 2024-05-06 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | S - Sale+OE | $309.00 | -1,600 | 34.1K | -4% | -$494.4K |
| D | 2024-05-08 | 2024-05-07 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | M - OptEx | $139.06 | +18.7K | 52.8K | +55% | +$2.59M |
| D | 2024-05-08 | 2024-05-08 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | G - Gift | $0.00 | -4,500 | 35.9K | -11% | $0 |
| D | 2024-05-08 | 2024-05-07 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | F - Tax | $314.45 | -12.3K | 40.4K | -23% | -$3.88M |
| M | 2024-05-06 | 2024-05-02+ | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | S - Sale | $312.00 | -1,863 | 21.5K | -8% | -$581.3K |
| 2024-05-01 | 2024-04-29 | HCA | Dennis Robert J | Dir | A - Grant | $0.00 | +963 | 25.6K | +4% | $0 | |
| D | 2024-05-01 | 2024-05-01 | HCA | Marks Mike A | EVP, CFO | G - Gift | $0.00 | -566 | 2,237 | -20% | $0 |
| 2024-05-01 | 2024-04-29 | HCA | Riley Wayne Joseph | Dir | A - Grant | $0.00 | +610 | 13.9K | +5% | $0 | |
| 2024-05-01 | 2024-04-29 | HCA | MICHELSON MICHAEL W | Dir | A - Grant | $0.00 | +1,091 | 10.5K | +12% | $0 | |
| 2024-05-01 | 2024-04-29 | HCA | Smith Andrea B | Dir | A - Grant | $0.00 | +610 | 3,512 | +21% | $0 | |
| 2024-05-01 | 2024-04-29 | HCA | CROFTON MEG | Dir | A - Grant | $0.00 | +610 | 6,331 | +11% | $0 | |
| 2024-05-01 | 2024-04-29 | HCA | Johnston Hugh F | Dir | A - Grant | $0.00 | +610 | 2,640 | +30% | $0 | |
| 2024-05-01 | 2024-04-29 | HCA | FRIST THOMAS F III | Dir, 10% | A - Grant | $0.00 | +1,284 | 13.5K | +11% | $0 | |
| 2024-05-01 | 2024-04-29 | HCA | Frist William R | Dir, 10% | A - Grant | $0.00 | +963 | 11.9K | +9% | $0 | |
| 2024-05-01 | 2024-04-29 | HCA | DEPARLE NANCY ANN | Dir | A - Grant | $0.00 | +610 | 20.8K | +3% | $0 | |
| D | 2024-03-20 | 2024-03-18 | HCA | Wasserman Chad J | SVP, CIO | M - OptEx | $101.16 | +2,100 | 4,020 | +109% | +$212.4K |
| D | 2024-03-20 | 2024-03-18 | HCA | Wasserman Chad J | SVP, CIO | F - Tax | $327.17 | -1,224 | 2,796 | -30% | -$400.5K |
| DM | 2024-03-20 | 2024-03-18+ | HCA | Wasserman Chad J | SVP, CIO | S - Sale+OE | $327.92 | -1,220 | 1,576 | -44% | -$400.1K |
| 2024-02-21 | 2024-02-16 | HCA | RUTHERFORD BILL B | CFO, EVP | A - Grant | $0.00 | +22.0K | 30.4K | +260% | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | RUTHERFORD BILL B | CFO, EVP | F - Tax | $308.55 | -8,177 | 22.3K | -27% | -$2.52M | |
| 2024-02-21 | 2024-02-16 | HCA | Wasserman Chad J | SVP, CIO | A - Grant | $0.00 | +2,040 | 2,419 | +538% | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | Wasserman Chad J | SVP, CIO | F - Tax | $308.55 | -499 | 1,920 | -21% | -$154.0K | |
| 2024-02-21 | 2024-02-16 | HCA | Foster Jon M | EVP, COO | A - Grant | $0.00 | +16.3K | 27.8K | +142% | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | Foster Jon M | EVP, COO | F - Tax | $308.55 | -5,950 | 21.8K | -21% | -$1.84M | |
| 2024-02-21 | 2024-02-16 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | A - Grant | $0.00 | +5,020 | 25.3K | +25% | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | Torres Kathryn A. | SVP-Payer Contracting, Align | F - Tax | $308.55 | -1,976 | 23.3K | -8% | -$609.7K | |
| 2024-02-21 | 2024-02-16 | HCA | Akdamar Erol R | Group Pres | F - Tax | $308.55 | -2,561 | 5,139 | -33% | -$790.2K | |
| 2024-02-21 | 2024-02-16 | HCA | Akdamar Erol R | Group Pres | A - Grant | $0.00 | +7,700 | 7,700 | New | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | Wyatt Christopher F. | SVP, Ctrl | F - Tax | $308.55 | -1,976 | 40.4K | -5% | -$609.7K | |
| 2024-02-21 | 2024-02-16 | HCA | Wyatt Christopher F. | SVP, Ctrl | A - Grant | $0.00 | +5,020 | 42.4K | +13% | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | Mosier Sammie S | SVP, Chief Nurse Executive | F - Tax | $308.55 | -1,068 | 10.4K | -9% | -$329.5K | |
| M | 2024-02-21 | 2024-02-16 | HCA | Mosier Sammie S | SVP, Chief Nurse Executive | A - Grant | $0.00 | +3,820 | 9,846 | +63% | $0 |
| 2024-02-21 | 2024-02-16 | HCA | Hammett Richard A | Group Pres | A - Grant | $0.00 | +5,500 | 19.7K | +39% | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | Hammett Richard A | Group Pres | F - Tax | $308.55 | -1,762 | 17.9K | -9% | -$543.7K | |
| 2024-02-21 | 2024-02-16 | HCA | Billington Phillip G | SVP-Internal Audit Services | A - Grant | $0.00 | +3,780 | 53.6K | +8% | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | Billington Phillip G | SVP-Internal Audit Services | F - Tax | $308.55 | -1,022 | 52.6K | -2% | -$315.3K | |
| 2024-02-21 | 2024-02-16 | HCA | McManus Timothy M | Group Pres | A - Grant | $0.00 | +6,280 | 25.4K | +33% | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | McManus Timothy M | Group Pres | F - Tax | $308.55 | -2,002 | 23.4K | -8% | -$617.7K | |
| 2024-02-21 | 2024-02-16 | HCA | Reiner Deborah M | SVP - Mktg, Comms | F - Tax | $308.55 | -1,510 | 6,824 | -18% | -$465.9K | |
| 2024-02-21 | 2024-02-16 | HCA | Reiner Deborah M | SVP - Mktg, Comms | A - Grant | $0.00 | +5,020 | 8,334 | +151% | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | HAZEN SAMUEL N | CEO, Dir | A - Grant | $0.00 | +78.4K | 296.1K | +36% | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | HAZEN SAMUEL N | CEO, Dir | F - Tax | $308.55 | -30.4K | 265.7K | -10% | -$9.38M | |
| M | 2024-02-21 | 2024-02-16 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | A - Grant | $0.00 | +17.0K | 41.9K | +68% | $0 |
| 2024-02-21 | 2024-02-16 | HCA | Cuffe Michael S. | EVP, Chief Clinical Off | F - Tax | $308.55 | -6,212 | 35.7K | -15% | -$1.92M | |
| 2024-02-21 | 2024-02-16 | HCA | Sowell Joseph A III | SVP, Chief Development Off | F - Tax | $308.55 | -2,005 | 4,275 | -32% | -$618.6K | |
| 2024-02-21 | 2024-02-16 | HCA | Sowell Joseph A III | SVP, Chief Development Off | A - Grant | $0.00 | +6,280 | 6,280 | New | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | F - Tax | $308.55 | -1,023 | 12.7K | -7% | -$315.6K | |
| 2024-02-21 | 2024-02-16 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | A - Grant | $0.00 | +3,780 | 13.7K | +38% | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | Cohen Jeffrey E. | SVP-Government Relations | F - Tax | $308.55 | -1,359 | 6,835 | -17% | -$419.3K | |
| 2024-02-21 | 2024-02-16 | HCA | Cohen Jeffrey E. | SVP-Government Relations | A - Grant | $0.00 | +3,780 | 8,194 | +86% | $0 | |
| 2024-02-21 | 2024-02-16 | HCA | Berres Jennifer | SVP, Chief Human Res. Off | A - Grant | $0.00 | +9,420 | 22.0K | +75% | $0 |
Purchase Sale Sale after option exercise All abbreviations